Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821586-25-000011
Filing Date
2025-05-12
Accepted
2025-05-12 16:04:09
Documents
92
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnlk-20250331.htm   iXBRL 10-Q 1062617
2 EX-10.1 mltx_2025q1xex101herculesl.htm EX-10.1 751996
3 EX-10.2 mltx_2025q1xex102formofres.htm EX-10.2 39274
4 EX-31.1 mltx_2025q1xex311dasilva.htm EX-31.1 10302
5 EX-31.2 mltx_2025q1xex312bodenstedt.htm EX-31.2 10214
6 EX-32.1 mltx_2025q1xex321dasilva.htm EX-32.1 4947
7 EX-32.2 mltx_2025q1xex322bodenstedt.htm EX-32.2 4884
  Complete submission text file 0001821586-25-000011.txt   8213985

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnlk-20250331.xsd EX-101.SCH 51001
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnlk-20250331_cal.xml EX-101.CAL 75602
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnlk-20250331_def.xml EX-101.DEF 337561
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnlk-20250331_lab.xml EX-101.LAB 659140
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnlk-20250331_pre.xml EX-101.PRE 527324
95 EXTRACTED XBRL INSTANCE DOCUMENT mnlk-20250331_htm.xml XML 857612
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39630 | Film No.: 25934650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)